Literature DB >> 24717342

Palm oil and blood lipid-related markers of cardiovascular disease: a systematic review and meta-analysis of dietary intervention trials.

Elena Fattore1, Cristina Bosetti1, Furio Brighenti1, Carlo Agostoni1, Giovanni Fattore1.   

Abstract

BACKGROUND: Palm oil (PO) may be an unhealthy fat because of its high saturated fatty acid content.
OBJECTIVE: The objective was to assess the effect of substituting PO for other primary dietary fats on blood lipid-related markers of coronary heart disease (CHD) and cardiovascular disease (CVD).
DESIGN: We performed a systematic review and meta-analysis of dietary intervention trials. Studies were eligible if they included original data comparing PO-rich diets with other fat-rich diets and analyzed at least one of the following CHD/CVD biomarkers: total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, TC/HDL cholesterol, LDL cholesterol/HDL cholesterol, triacylglycerols, apolipoprotein A-I and B, very-low-density lipoprotein cholesterol, and lipoprotein(a).
RESULTS: Fifty-one studies were included. Intervention times ranged from 2 to 16 wk, and different fat substitutions ranged from 4% to 43%. Comparison of PO diets with diets rich in stearic acid, monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs) showed significantly higher TC, LDL cholesterol, apolipoprotein B, HDL cholesterol, and apolipoprotein A-I, whereas most of the same biomarkers were significantly lower when compared with diets rich in myristic/lauric acid. Comparison of PO-rich diets with diets rich in trans fatty acids showed significantly higher concentrations of HDL cholesterol and apolipoprotein A-I and significantly lower apolipoprotein B, triacylglycerols, and TC/HDL cholesterol. Stratified and meta-regression analyses showed that the higher concentrations of TC and LDL cholesterol, when PO was substituted for MUFAs and PUFAs, were not significant in young people and in subjects with diets with a lower percentage of energy from fat.
CONCLUSIONS: Both favorable and unfavorable changes in CHD/CVD risk markers occurred when PO was substituted for the primary dietary fats, whereas only favorable changes occurred when PO was substituted for trans fatty acids. Additional studies are needed to provide guidance for policymaking.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24717342     DOI: 10.3945/ajcn.113.081190

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  31 in total

Review 1.  Palm oil and the heart: A review.

Authors:  Osaretin J Odia; Sandra Ofori; Omosivie Maduka
Journal:  World J Cardiol       Date:  2015-03-26

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 3.  Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment.

Authors:  Patty W Siri-Tarino; Sally Chiu; Nathalie Bergeron; Ronald M Krauss
Journal:  Annu Rev Nutr       Date:  2015       Impact factor: 11.848

Review 4.  Current Evidence Supporting the Link Between Dietary Fatty Acids and Cardiovascular Disease.

Authors:  Shatha Hammad; Shuaihua Pu; Peter J Jones
Journal:  Lipids       Date:  2015-12-30       Impact factor: 1.880

5.  Injury to hypothalamic Sim1 neurons is a common feature of obesity by exposure to high-fat diet in male and female mice.

Authors:  Eugene Nyamugenda; Marcus Trentzsch; Susan Russell; Tiffany Miles; Gunnar Boysen; Kevin D Phelan; Giulia Baldini
Journal:  J Neurochem       Date:  2019-02-11       Impact factor: 5.372

6.  Intake of Palm Olein and Lipid Status in Healthy Adults: A Meta-Analysis.

Authors:  Phooi Tee Voon; Sin Tien Lee; Tony Kock Wai Ng; Yen Teng Ng; Xiou Shuang Yong; Verna Kar Mun Lee; Augustine Soon Hock Ong
Journal:  Adv Nutr       Date:  2019-07-01       Impact factor: 8.701

7.  Oil palm natural diversity and the potential for yield improvement.

Authors:  Edson Barcelos; Sara de Almeida Rios; Raimundo N V Cunha; Ricardo Lopes; Sérgio Y Motoike; Elena Babiychuk; Aleksandra Skirycz; Sergei Kushnir
Journal:  Front Plant Sci       Date:  2015-03-27       Impact factor: 5.753

Review 8.  Indicators and Recommendations for Assessing Sustainable Healthy Diets.

Authors:  Maite M Aldaya; Francisco C Ibañez; Paula Domínguez-Lacueva; María Teresa Murillo-Arbizu; Mar Rubio-Varas; Beatriz Soret; María José Beriain
Journal:  Foods       Date:  2021-05-02

Review 9.  Tropical Oil Consumption and Cardiovascular Disease: An Umbrella Review of Systematic Reviews and Meta Analyses.

Authors:  Chanita Unhapipatpong; Prapimporn Chattranukulchai Shantavasinkul; Vijj Kasemsup; Sukanya Siriyotha; Daruneewan Warodomwichit; Sirikan Maneesuwannarat; Prin Vathesatogkit; Piyamitr Sritara; Ammarin Thakkinstian
Journal:  Nutrients       Date:  2021-05-04       Impact factor: 5.717

10.  Effects of Palm Stearin versus Butter in the Context of Low-Carbohydrate/High-Fat and High-Carbohydrate/Low-Fat Diets on Circulating Lipids in a Controlled Feeding Study in Healthy Humans.

Authors:  Parker N Hyde; Teryn N Sapper; Richard A LaFountain; Madison L Kackley; Alex Buga; Brandon Fell; Christopher D Crabtree; Stephen D Phinney; Vincent J Miller; Sarah M King; Ronald M Krauss; William J Kraemer; Jeff S Volek
Journal:  Nutrients       Date:  2021-06-05       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.